Pirfenidone in rheumatoid arthritis-associated interstitial lung disease - Authors' reply.

Hurwitz, Shelley; Maurer, Rie; Solomon, Joshua J; Rosas, Ivan O

Hurwitz, Shelley; Maurer, Rie; Solomon, Joshua J; Rosas, Ivan O.

Hurwitz S; Brigham and Women's Hospital, Boston, MA, USA.
Maurer R; Brigham and Women's Hospital, Boston, MA, USA.
Solomon JJ; National Jewish Health, Denver, CO, USA.
Rosas IO; Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: ivan.rosas@bcm.edu.

Lancet Respir Med ; 11(6): e52, 2023 06.

Article in English | MEDLINE | ID: covidwho-20237048

Subject(s)

Arthritis, Rheumatoid; Lung Diseases, Interstitial; Humans; Lung Diseases, Interstitial/etiology; Lung Diseases, Interstitial/complications; Arthritis, Rheumatoid/complications; Arthritis, Rheumatoid/drug therapy; Pyridones/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Rheumatoid / Lung Diseases, Interstitial Type of study: Etiology study / Risk_factors_studies Topics: Long Covid Limits: Humans Language: English Journal: Lancet Respir Med Year: 2023 Document Type: Article Affiliation country: S2213-2600(23)00131-5

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google